arrow_back Back to App

Improved Access to Medicare Drug Information

This act aims to make it easier for citizens to access information about drug costs and alternatives within the Medicare program. By 2027, insurance companies will be required to provide online tools that allow for quick checking of prices and treatment options, potentially helping to save money and make informed health decisions.
Key points
By January 1, 2027, prescription drug plan sponsors under Medicare Part D must implement electronic real-time benefit tools.
These tools will enable patients to quickly compare drug costs and find cheaper alternatives, potentially reducing their out-of-pocket medication expenses.
The goal is to increase transparency and empower citizens to make better decisions regarding their treatment and personal finances.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 118_HR_7512
Sponsor: Rep. Arrington, Jodey C. [R-TX-19]
Process start date: 2024-03-01
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

Real-Time Benefit Tool Implementation Act

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 118_HR_7512.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2024-03-01.

What are the main provisions?

Key points include:

  • By January 1, 2027, prescription drug plan sponsors under Medicare Part D must implement electronic real-time benefit tools.
  • These tools will enable patients to quickly compare drug costs and find cheaper alternatives, potentially reducing their out-of-pocket medication expenses.
  • The goal is to increase transparency and empower citizens to make better decisions regarding their treatment and personal finances.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Arrington, Jodey C. [R-TX-19].

What is the latest detailed status?

The latest detailed status is: Reported (Amended) by the Committee on Ways and Means. H. Rept. 118-549, Part I.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-25.

CATEGORIES

Health Benefits